Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal of Cutaneous Pathology
|
November 20, 2014
Recurrent atypical fibroxanthoma with satellite metastasis
Solomon S Lee, James M Lewis, Kevin Liaw, et al.
Journal of Digital Imaging
|
September 21, 2013
Pick up a book or "google it?" a survey of radiologist and trainee-preferred references and resources
Blake D Niederhauser, Kevin Liaw, Robert J McDonald, et al.
Biomacromolecules
|
October 28, 2020
Dendrimer-Mediated Targeted Delivery of Rapamycin to Tumor-Associated Macrophages Improves Systemic Treatment of Glioblastoma
Anjali Sharma, Kevin Liaw, Rishi Sharma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 18, 2021
Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma
Rishi Sharma, Kevin Liaw, Anjali Sharma, et al.
Bioengineering & Translational Medicine
|
May 24, 2021
Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma
Kevin Liaw, Rajsekhar Reddy, Anjali Sharma, et al.
Pediatric Radiology
|
February 26, 2009
The clinical impact of the radiology report in wheezing and nonwheezing febrile children: a survey of clinicians
Stephanie E Spottswood, Kevin Liaw, Marta Hernanz-Schulman, et al.
Journal for Immunotherapy of Cancer
|
December 2, 2024
Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells
Daniel H Park, Pratik S Bhojnagarwala, Kevin Liaw, et al.
Molecular Therapy Oncolytics
|
September 12, 2022
<i>In vivo</i> DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme
Pratik S Bhojnagarwala, Ryan P O'Connell, Daniel Park, et al.
Science Advances
|
February 4, 2020
Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
Anjali Sharma, Rishi Sharma, Zhi Zhang, et al.
Journal for Immunotherapy of Cancer
|
June 4, 2024
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma
Ryan P O'Connell, Kevin Liaw, Nils Wellhausen, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal of Cutaneous Pathology
|
November 20, 2014
Recurrent atypical fibroxanthoma with satellite metastasis
Solomon S Lee, James M Lewis, Kevin Liaw, et al.
Journal of Digital Imaging
|
September 21, 2013
Pick up a book or "google it?" a survey of radiologist and trainee-preferred references and resources
Blake D Niederhauser, Kevin Liaw, Robert J McDonald, et al.
Biomacromolecules
|
October 28, 2020
Dendrimer-Mediated Targeted Delivery of Rapamycin to Tumor-Associated Macrophages Improves Systemic Treatment of Glioblastoma
Anjali Sharma, Kevin Liaw, Rishi Sharma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 18, 2021
Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma
Rishi Sharma, Kevin Liaw, Anjali Sharma, et al.
Bioengineering & Translational Medicine
|
May 24, 2021
Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma
Kevin Liaw, Rajsekhar Reddy, Anjali Sharma, et al.
Pediatric Radiology
|
February 26, 2009
The clinical impact of the radiology report in wheezing and nonwheezing febrile children: a survey of clinicians
Stephanie E Spottswood, Kevin Liaw, Marta Hernanz-Schulman, et al.
Journal for Immunotherapy of Cancer
|
December 2, 2024
Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells
Daniel H Park, Pratik S Bhojnagarwala, Kevin Liaw, et al.
Molecular Therapy Oncolytics
|
September 12, 2022
<i>In vivo</i> DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme
Pratik S Bhojnagarwala, Ryan P O'Connell, Daniel Park, et al.
Science Advances
|
February 4, 2020
Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders
Anjali Sharma, Rishi Sharma, Zhi Zhang, et al.
Journal for Immunotherapy of Cancer
|
June 4, 2024
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma
Ryan P O'Connell, Kevin Liaw, Nils Wellhausen, et al.
Page
of 4